NF-kappaB阻塞和瘤性Ras触发了侵袭性人类表皮瘤
Maya Dajee1, Mirella Lazarov, Jennifer Y Zhang
1Veterans Affairs Palo Alto Healthcare System and the Program in Epithelial Biology, Stanford University School of Medicine, Stanford, California 94305, USA.
Nature
|February 7, 2003
概括
核因子kappa B (NF-kappaB) 和瘤性Ras通常会在人类表皮细胞中阻止细胞循环. 用致癌的Ras阻断NF-kappaB可以导致状细胞癌.
科学领域:
- 在瘤学瘤学.
- 细胞生物学 细胞生物学
- 皮肤病学 皮肤病学
背景情况:
- 核因子NF-kappaB和瘤性Ras调节表皮中的细胞增殖,这是人类癌症的常见部位.
- 虽然它们与小鼠状细胞癌有关,但它们在人类表皮细胞中的确切作用尚不清楚.
- 针对Ras和NF-kappaB通路的治疗方法正在开发中,用于人类癌症治疗.
研究的目的:
- 研究改变正常人表皮细胞中NF-kappaB和瘤性Ras功能的影响.
- 确定这些因素影响细胞循环停止和瘤发生的机制.
- 评估NF-kappaB阻塞促进Ras诱导的恶性转变的潜力.
主要方法:
- 使用了正常的人类表皮细胞.
- 研究了NF-kappaB和瘤原Ras对细胞循环停止的影响.
- 检查了IkappaBalpha在调节Ras诱导的增长停止中的作用.
- 评估了人体细胞瘤发生的依赖性对拉米宁5和α6β4整合素.
主要成果:
- 发现NF-kappaB和瘤性Ras都会在正常的人类表皮细胞中触发细胞循环停止.
- 瘤性Ras诱导的生长停止可以通过IkappaBalpha介导的NF-kappaB阻断来克服.
- 这种阻塞,与瘤性Ras结合,产生了类似状细胞癌的恶性人体表皮组织.
- 在这种情况下,人类细胞瘤发生取决于拉米宁5和α6β4整合蛋白.
结论:
- NF-kappaB和瘤性Ras作为人类表皮细胞循环控制的关键调节剂.
- 伊卡帕巴尔法可以绕过致癌性Ras.的增长抑制信号.
- 拉斯和NF-kappaB阻断的联合作用可以诱导侵袭性人类瘤,突出潜在的治疗脆弱性.
相关概念视频
NF-κB-dependent Signaling Pathway
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Mitogens and the Cell Cycle
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Abnormal Proliferation
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
The Ras Gene
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
Ras is a superfamily...
Small GTPases - Ras and Rho
Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
Three regulatory proteins control their activity:
MAPK Signaling Cascades
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...


